Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas
Open Access
- 27 February 2025
- journal article
- Published by Impact Journals, LLC in Aging
- Vol. null (2) , 550-562
Abstract
Radiotherapy is a crucial treatment option for various cancers. However, the results of radiotherapy can vary widely across different cancer types and even among patients with the same type of cancer. This variability presents a major challenge in optimizing treatment strategies and improving patient survival. Here, we collected radiotherapy phenotype and expression data from 32 TCGA cancer datasets and performed overall survival analysis for 32 cancer types. Additionally, we conducted a signaling pathway enrichment analysis to identify key pathways involved in radiotherapy resistance and sensitivity. Our findings show that radiotherapy improves survival outcomes in certain cancer types, such as glioblasoma multiforme (GBM), while worsening outcomes in others, such as low-grade glioma (LGG). Next, we focused on exploring the differences in radiotherapy outcomes between GBM and LGG, focusing on the molecular mechanisms contributing to these variations. We identify differential regulation of pathways related to programmed cell death, DNA repair, telomere maintenance, chromosome condensation, antiviral responses, and interferon signaling between GBM and LGG patients perhaps explaining radiotherapy efficacy. A genetic analysis confirmed the importance of immune response and radiotherapy outcome for LGG patients. These insights underscore the importance of personalized treatment approaches and the need for further research to improve radiotherapy outcomes in cancer patients.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- ATRXLoss Increases Sensitivity to Proton Radiotherapy Compared to X-Ray Radiotherapy in Glioma Stem Cells via Secondary NecrosisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and/or Adjuvant ChemotherapyAdvances in Radiation Oncology, 2021
- Combining Radiation Therapy With Interferons: Back to the FutureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Novel Therapies for GlioblastomaCurrent Neurology and Neuroscience Reports, 2020
- Molecular Pathogenesis of Low-Grade GliomaNeurosurgery Clinics of North America, 2019
- EGFR confers radioresistance in human oropharyngeal carcinoma by activating endoplasmic reticulum stress signaling PERK‐eIF2α‐GRP94 and IRE1α‐XBP1‐GRP78Cancer Medicine, 2018
- The role of radiation in treating glioblastoma: here to stayJournal of Neuro-Oncology, 2017
- EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selectionPharmacology & Therapeutics, 2015
- PROGRESS IN CLINICAL NEUROSCIENCES: Advances in the Management of Low-Grade GliomasCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2005
- Potential significance of 11C-methionine PET as a marker for the radiosensitivity of low-grade gliomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002